1. Home
  2. ONCY

ONCY

Oncolytics Biotech Inc.

Logo Oncolytics Biotech Inc.

Health Care

Pharmaceuticals and Biotechnology

Nasdaq

as 04-19-2024 2:32pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.

Founded: 1998 Country:
Canada
Canada
Employees: N/A City: N/A
Market Cap: 81.5M IPO Year: 1999
Target Price: $5.50 AVG Volume (30 days): 386.4K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.41 EPS Growth: N/A
52 Week Low/High: $0.88 - $3.39 Next Earning Date: 05-03-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 565.08%

Share on Social Networks: